Search

everythinglearnresearchcommunity

for

Search:↓

PRP shows promise but lacks consistent evidence and regulation.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Female pattern hair loss affects crown, increases with age, and has limited treatments.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Post-finasteride syndrome can cause lasting sexual, physical, and mental health issues with limited treatment options.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Platelet-rich plasma therapy might help treat some kinds of hair loss.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.